Americas Gold Nanoparticles Market Research Report - Forecast to 2023

Americas Gold Nanoparticles Market Research Report - Forecast to 2023

ID: MRFR/HC/0623-HCRR | November, 2018 | Region: Global | 120 pages | Half-Cooked Research Reports

Americas Gold Nanoparticles Market Research Information: By Type (Nanorods, Nanoshells, Nanocages), Application (Medical & Dentistry, Catalysis, Others), End-User (Hospitals, Diagnostic Center, Research & Academic Institute, Other) - Forecast Till 2023


Market Scenario


Recent advancements in nanotechnology have given rise to a generation of various types of nanoparticles, such as gold nanoparticles (AuNPs), specially designed to act as radiosensitizers and photothermal sensitizing agents. Functionalized AuNPS are employed in combination with non-ionizing and ionizing radiations to improve the efficacy of cancer treatment while at the same time sparing normal tissues. Some of the common applications of gold nanoparticles are anti-microbial activity, in nanowires and catalyst, photodynamic therapy, as substrates to enable the measurement of vibrational energies, and detection of biomarkers in the diagnosis of cancer, infectious agent, and heart diseases.


The most promising applications of nanoparticles are in cardiovascular medicines because the biological barriers associated with them are negligible.


Gold nanoparticles in the biosensor technology play a vital role in the targeted sensing of selective bio-molecules using functionalized gold nanoparticles. Gold nanoparticles-based sensors are expected to change the foundations of sensing and detecting bio-molecules. The application of gold nanoparticles in smart sensor fabrication will lead to the detection of specific biomolecules.


Notably, the growing adoption of nanotechnology in the healthcare industry and escalating prevalence of cancer and other chronic diseases are the key factors driving the gold nanoparticles market. According to the report published in the Centers for Disease Control and Prevention (CDC) in 2017, nearly 92.1 million adults were dealing with at least one type of cardiovascular disease. The CDC has also stated that out of the total annual healthcare expenditure, i.e., USD 27 trillion, 86% is for people with chronic health conditions in the United States. The increasing prevalence of chronic diseases, especially cardiovascular diseases and cancer, strongly promotes the growth of the market.


Various other push factors such as the increasing demand for medical imaging, rising technological advancements, increasing participation of market leaders, increasing government assistance, and amendments in regulatory framework are continuously contributing to the growth of the Americas gold nanoparticles market.


Despite these drivers, there are some issues associated with the gold nanoparticles market. Few challenges in research and development, stringent regulations of the U.S. Food and Drug Administration (FDA), the high cost of production, difficult handling of nanomaterial, and poor healthcare systems in low- and middle-income countries may hinder the growth of the gold nanoparticles market to an extent.


It is estimated that the gold nanoparticles market is expected to grow at a CAGR 16.5% during the forecast period of 2017–2023.


Research Methodology


 gold nanoparticles market


Sources: Annual reports, Press release, White paper, and Company presentation


Intended Audience



  • Pharmaceutical Companies

  • Research and Development (R&D) Companies

  • Diagnostic Laboratories

  • Government Research Institutes

  • Academic Institutes and Universities


Segmentation


The American gold nanoparticles market is segmented on the basis of type of gold nanoparticles, application, and end-user.


On the basis of the type of gold nanoparticles, the market is segmented into Nanorods, Nanoshells, and Nanocages


On the basis of the application, the market is classified into medical and dentistry, catalysis, electronics, and others. Medical and dentistry is further classified as Nano Oncology, Nano Neurology, Nano Imaging, Nano Cardiology, Nano Immunology, and Therapeutics. The others segment includes glass, cosmetics, and photometry.


On the basis of end-user, the market is segmented into hospitals, diagnostics centers, research and academic institutes, and others.


Regional Analysis


The American gold nanoparticles market comprises of two regions namely North America and South America. North America is the largest market whose growth is attributed to the rising technological advancements, high healthcare expenditure, and rising cases of cancer. According to the statistics suggested by the National Cancer Institute, around 1,685,210 new cases of cancer were diagnosed in the United States, and 595,690 died from the disease. It is also reported that the cancer mortality is higher among men than women, i.e., 207.9 per 100,000 men and 145.4 per 100,000 women. The condition is found to be the highest in African American men, i.e., 261.5 per 100,000, and lowest in Asia Pacific Islander women, i.e., 91.2 per 100,000. Owing to the tunable and highly sensitive optical and electronic properties of gold nanoparticles, they are now widely used in bio-imaging and phototherapy. The implementation of theranostic nanomaterial has a great potential for improved cancer treatments and reduced side effects.


According to the statistical data suggested by the Centers for Disease Control and Prevention (CDC), the total health expenditure in the United States was 3.2 trillion in 2015. Whereas, hospital care accounted for a share of 32.3%. 


Key Players


Some of key the players in the Americas gold nanoparticles market are Appolo Biolife, BBI Solutions, Cytodiagnostics, Goldsol, Innova Biosciences, Johnson Matthey Plc, Meliorum Technologies, Inc., Metalor, NanoBio Chemicals India Pvt. Ltd, nanoComposix, NanoHybrids Corp., Nanopartz Inc., NanoRods LLC, Nanosphere, Nanostellar, Sigma-Aldrich, Solaris Nanosciences, TANAKA HOLDINGS, and others.


 

Table of Contents:

Chapter 1. Report Prologue

Chapter 2. Market Introduction

2.1 Definition

2.2 Scope of the Study

2.2.1 Research Objective

2.2.2 Assumptions

2.2.3 Limitations

Chapter 3. Research Methodology

3.1 Introduction

3.2 Primary Research

3.3 Secondary research

3.4 Market Size Estimation

Chapter 4. Market Dynamics

4.1 Drivers

4.2 Restraints

4.3 Opportunities

4.4 Challenges

4.5 Macroeconomic Indicators

4.6 Technology Trends & Assessment

Chapter 5. Market Factor Analysis

5.1 Porter’s Five Forces Analysis

5.1.1 Bargaining Power of Suppliers

5.1.2 Bargaining Power of Buyers

5.1.3 Threat of New Entrants

5.1.4 Threat of Substitutes

5.1.5 Intensity of Rivalry

5.2 Value Chain Analysis

5.3 Investment Feasibility Analysis

5.4 Pricing Analysis

Chapter 6. Americas Gold Nanoparticles Market, by Type

6.1 Introduction

6.2 Nanorods

6.2.1 Market Estimates & Forecast, 2017–2023

6.3 Nanoshells

6.3.1 Market Estimates & Forecast, 2017–2023

6.4 Nanocages

6.4.1 Market Estimates & Forecast, 2017–2023

Chapter 7. Americas Gold Nanoparticles Market, by Application

7.1 Introduction

7.2 Medical & Dentistry

7.2.1 Market Estimates & Forecast, 2017–2023

7.3 Catalysis

7.3.1 Market Estimates & Forecast, 2017–2023

7.4 Others

7.4.1 Market Estimates & Forecast, 2017–2023



Chapter 8. Americas Gold Nanoparticles Market, by End-User

8.1 Introduction

8.2 Hospital

8.2.1 Market Estimates & Forecast, 2017–2023

8.3 Diagnostics Centers

8.3.2 Market Estimates & Forecast, 2017–2023

8.4 Research and Academic Institutes

8.4.1 Market Estimates & Forecast, 2017–2023

8.5 Others

8.5.2 Market Estimates & Forecast, 2017–2023

Chapter 9. Americas Gold Nanoparticles Market, by Region

9.1 Introduction

9.1.1 North America

9.1.1.1 U.S.

9.1.1.2 Canada

9.1.2 South America

9.2 Europe

9.2.1 Western Europe

9.2.1.1 Germany

9.2.1.2 France

9.2.1.3 Italy

9.2.1.4 Spain

9.2.1.5 U.K.

9.2.1.6 Rest of Western Europe

9.2.2 Eastern Europe

9.3 Asia Pacific

9.3.1 Japan

9.3.2 China

9.3.3 India

9.3.4 Australia

9.3.5 Republic of Korea

9.3.6 Rest of Asia Pacific

9.4 The Middle East & Africa

9.4.1 United Arab Emirates

9.4.2 Saudi Arabia

9.4.3 Oman

9.4.4 Kuwait

9.4.5 Qatar

9.4.6 Rest of the Middle East & Africa

Chapter 10 Company Landscape

10.1 Introduction

10.2 Market Share Analysis

10.3 Key Development & Strategies

10.3.1 Key Developments

Chapter 11 Company Profiles

11.1 Appolo Biolife

11.1.1 Company Overview

11.1.2 Types Overview

11.1.3 Financials

11.1.4 SWOT Analysis

11.2 BBI Solutions

11.2.1 Company Overview

11.2.2 Types Overview

11.2.3 Financial Overview

11.2.4 Key Developments

11.2.5 SWOT Analysis

11.3 Cytodiagnostics

11.3.1 Company Overview

11.3.2 Types Overview

11.3.3 Financial Overview

11.3.4 Key Development

11.3.5 SWOT Analysis

11.4 Goldsol

11.4.1 Company Overview

11.4.2 Types/Business Segment Overview

11.4.3 Financial Overview

11.4.4 Key Development

11.4.5 SWOT Analysis

11.5 Innova Biosciences

11.5.1 Company Overview

11.5.2 Types Overview

11.5.3 Financial overview

11.5.4 Key Developments

11.6 Johnson Matthey Plc

11.6.1 Company Overview

11.6.2 Types Overview

11.6.3 Financial Overview

11.6.4 Key Developments

11.7 MELIORUM TECHNOLOGIES, INC.

11.7.1 Overview

11.7.2 Types Overview

11.7.3 Financials

11.7.4 Key Developments

11.7.5 SWOT Analysis

11.8 Others

Chapter 12 MRFR Conclusion

12.1 Key Findings

12.1.1 From CEO’s View Point

12.1.2 Unmet Needs of the Market

12.2 Key Companies to Watch

12.3 Prediction of Gold Nanoparticles Industry

Chapter 13 Appendix



LIST OF TABLES

Table 1 Gold Nanoparticles Industry Synopsis, 2017–2023

Table 2 Gold Nanoparticles Market Estimates & Forecast, 2017–2023, (USD Million)

Table 3 Gold Nanoparticles Market, by Region, 2017–2023, (USD Million)

Table 4 Gold Nanoparticles Market, by Type, 2017–2023, (USD Million)

Table 5 Gold Nanoparticles Market, by Application, 2017–2023, (USD Million)

Table 6 Gold Nanoparticles Market, by End-User, 2017–2023, (USD Million)

Table 7 North America Gold Nanoparticles Market, by Type, 2017–2023, (USD Million)

Table 8 North America Gold Nanoparticles Market, by Application, 2017–2023, (USD Million)

Table 9 North America Gold Nanoparticles Market, by End-User, 2017–2023, (USD Million)

Table 10 US Gold Nanoparticles Market, by Type, 2017–2023, (USD Million)

Table 11 US Gold Nanoparticles Market, by Application, 2017–2023, (USD Million)

Table 12 US Gold Nanoparticles Market, by End-User, 2017–2023, (USD Million)

Table 13 Canada Gold Nanoparticles Market, by Type, 2017–2023, (USD Million)

Table 14 Canada Gold Nanoparticles Market, by Application, 2017–2023, (USD Million)

Table 15 Canada Gold Nanoparticles Market, by End-User, 2017–2023, (USD Million)

Table 16 South America Gold Nanoparticles Market, by Type, 2017–2023, (USD Million)

Table 17 South America Gold Nanoparticles Market, by Application, 2017–2023, (USD Million)

Table 18 South America Gold Nanoparticles Market, by End-User, 2017–2023, (USD Million)





LIST OF FIGURES

Figure 1 Research Process

Figure 2 Segmentation of the Gold Nanoparticles Market

Figure 3 Segmentation Market Dynamics for Gold Nanoparticles Market

Figure 4 Americas Gold Nanoparticles Market Share, by Type 2016

Figure 5 Americas Gold Nanoparticles Market Share, by Application 2016

Figure 6 Americas Gold Nanoparticles Market Share, by End-User, 2016

Figure 7 Americas Gold Nanoparticles Market Share, by Region, 2016

Figure 8 North America Gold Nanoparticles Market Share, by Country, 2016

Figure 9 Americas Gold Nanoparticles Market: Company Share Analysis, 2016 (%)

Figure 10 Appolo Biolife: Key Financials

Figure 11 Appolo Biolife Segmental Revenue

Figure 12 Appolo Biolife: Geographical Revenue

Figure 13 BBI Solutions: Key Financials

Figure 14 BBI Solutions: Segmental Revenue

Figure 15 BBI Solutions: Geographical Revenue

Figure 16 Cytodiagnostics: Key Financials

Figure 17 Cytodiagnostics: Segmental Revenue

Figure 18 Cytodiagnostics: Geographical Revenue

Figure 19 Goldsol: Key Financials

Figure 20 Goldsol: Segmental Revenue

Figure 21 Goldsol: Geographical Revenue

Figure 22 Innova Biosciences: Key Financials

Figure 23 Innova Biosciences: Segmental Revenue

Figure 24 Innova Biosciences Geographical Revenue

Figure 25 Johnson Matthey Plc: Key Financials

Figure 26 Johnson Matthey Plc: Segmental Revenue

Figure 27 Johnson Matthey Plc: Geographical Revenue

Figure 28 MELIORUM TECHNOLOGIES, INC.: Key Financials

Figure 29 MELIORUM TECHNOLOGIES, INC.: Segmental Revenue

Figure 30 MELIORUM TECHNOLOGIES, INC.: Geographical Revenue